Search by Drug Name or NDC

    NDC 63304-0116-13 Pazopanib 200 mg/1 Details

    Pazopanib 200 mg/1

    Pazopanib is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by SUN PHARMACEUTICAL INDUSTRIES, INC.. The primary component is PAZOPANIB HYDROCHLORIDE.

    Product Information

    NDC 63304-0116
    Product ID 63304-116_3aa752ae-7fad-4728-bded-7a3e1a4b3589
    Associated GPIs
    GCN Sequence Number 065777
    GCN Sequence Number Description pazopanib HCl TABLET 200 MG ORAL
    HIC3 V1Q
    HIC3 Description ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS
    GCN 27829
    HICL Sequence Number 036709
    HICL Sequence Number Description PAZOPANIB HCL
    Brand/Generic Generic
    Proprietary Name Pazopanib
    Proprietary Name Suffix n/a
    Non-Proprietary Name Pazopanib
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/1
    Substance Name PAZOPANIB HYDROCHLORIDE
    Labeler Name SUN PHARMACEUTICAL INDUSTRIES, INC.
    Pharmaceutical Class Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215837
    Listing Certified Through 2024-12-31

    Package

    NDC 63304-0116-13 (63304011613)

    NDC Package Code 63304-116-13
    Billing NDC 63304011613
    Package 120 TABLET, FILM COATED in 1 BOTTLE (63304-116-13)
    Marketing Start Date 2023-10-20
    NDC Exclude Flag N
    Pricing Information N/A